Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:214 (29 July), doi:10.1136/bmj.333.7561.214
Food labels should list these as well as cholesterol and saturated fat
| The first 150 words of the full text of this article appear below. |
Arecent systematic review by Mozaffarian and colleagues in the New England Journal of Medicine advocated that people should reduce or stop their dietary intake of trans fatty acids to minimise the related risk of coronary heart disease.1 Trans fatty acidsunsaturated fatty acids with at least one double bond in the trans molecular configurationare produced by partial hydrogenation of vegetable oils. This is a process that converts vegetable oils into semisolid fats which have no known nutritional value but are widely used in margarines, in commercial cooking, and in manufactured foods.2
Reliable evidence for the effects of trans fatty acids and other types of fat on blood lipids comes from the "metabolic ward" studies (in which participants are admitted to wards specialising in metabolic studies). Typically, participants in these studies consumed isocaloric diets under controlled conditions that exchanged the amount and type of fat for complex carbohydrate and the effects
Robert Clarke, honorary consultant in public health medicine
Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Building, University of Oxford, Oxford OX3 7LF
(robert.clarke@ctsu.ox.ac.uk)
Sarah Lewington, senior research fellow
Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Building, University of Oxford, Oxford OX3 7LF
Read all Rapid Responses